PharmaDrug Announces pre-IND Meeting Request Granted by FDA for Oral Antiviral Drug Cepharanthine for the Treatment of… Sep 28, 2021
MINDCURE Launches “Desire Project” To Treat Female Hypoactive Sexual Desire Disorder With MDMA-Assisted… Sep 27, 2021
InMed Pharmaceuticals Reports Full Year Fiscal 2021 Financial Results and Provides Business Update Sep 24, 2021
MINDCURE Signs Exclusive Digital Clinical Data Licensing Agreement with ATMA Journey Centers Sep 23, 2021
Tryp Therapeutics Submits IND Application For Phase 2a Clinical Trial In Eating Disorders Sep 22, 2021
